Ratings by Nephron (Eric Percher)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Elevance | ELV | New Coverage | Hold (N/A) |
323.05 (407.96) |
26.28% | Details | |
| 4/20/2026 | Oscar Health Inc | OSCR | New Coverage | Buy (N/A) |
15.79 (31.25) |
97.91% | Details | |
| 4/20/2026 | UnitedHealth Group | UNH | New Coverage | Buy (N/A) |
324.63 (415.43) |
27.97% | Details | |
| 4/20/2026 | Molina Healthcare | MOH | New Coverage | Buy (N/A) |
148.97 (227.80) |
52.92% | Details | |
| 4/20/2026 | CIGNA | CI | New Coverage | Hold (N/A) |
278.64 (277.81) |
-0.3% | Details | |
| 4/20/2026 | CVS Health | CVS | New Coverage | Hold (N/A) |
77.30 (101.92) |
31.85% | Details | |
| 4/20/2026 | Centene | CNC | New Coverage | Buy (N/A) |
38.17 (65.21) |
70.84% | Details | |
| 3/9/2026 | Hims and Hers | HIMS | Upgrade | Buy (Hold) |
15.74 (38.57) |
145.04% | Details | |
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Hold (N/A) |
40.52 (42.71) |
5.4% | Details | |
| 2/25/2025 | Hims and Hers | HIMS | Downgrade | Hold (Buy) |
51.31 (15.74) |
-69.32% | Details | |
| 12/3/2024 | Hims and Hers | HIMS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Hims and Hers | HIMS | New Coverage | Buy (N/A) |
21.73 (38.57) |
77.5% | Details | |
| 11/21/2022 | Walgreens Boosts Alliance | WBA | Upgrade | Hold (Sell) |
39.75 (11.98) |
-69.86% | Details |
